Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial

Cheong, PK, Ford, AC orcid.org/0000-0001-6371-4359, Cheung, CKY et al. (5 more authors) (2018) Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology and Hepatology, 3 (12). pp. 837-844. ISSN 2468-1253

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Elsevier Ltd. All rights reserved. This is an author produced version of a paper published in The Lancet Gastroenterology and Hepatology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: December 2018
  • Accepted: 4 September 2018
  • Published (online): 22 October 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 01 Nov 2018 12:46
Last Modified: 22 Apr 2019 00:45
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S2468-1253(18)30303-0

Share / Export

Statistics